Clinical usefulness of slow pathway ablation in patients with both paroxysmal atrioventricular nodal reentrant tachycardia and atrial fibrillation

P Delise; L Gianfranchi; N Paparella; M Brignole; C Menozzi; S Themistoclakis; R Mantovan; A Bonso; L Corò; A Vaglio; M Ragazzo; P Alboni; A Raviele

doi:10.1016/s0002-9149(97)00157-4

Clinical usefulness of slow pathway ablation in patients with both paroxysmal atrioventricular nodal reentrant tachycardia and atrial fibrillation

Am J Cardiol. 1997 May 15;79(10):1421-3. doi: 10.1016/s0002-9149(97)00157-4.

Authors

P Delise¹, L Gianfranchi, N Paparella, M Brignole, C Menozzi, S Themistoclakis, R Mantovan, A Bonso, L Corò, A Vaglio, M Ragazzo, P Alboni, A Raviele

Affiliation

¹ Cardiology Division, Umberto I Hospital Mestre, Venice, Venezia, Italy.

PMID: 9165175
DOI: 10.1016/s0002-9149(97)00157-4

Abstract

Some patients with atrioventricular (AV) node reentrant tachycardia (AVN RT) also presented with atrial fibrillation (AF). In this study we demonstrate that slow pathway ablation is able to suppress both AVN RT and AF in subjects without structural heart abnormalities, whereas in patients with structural heart abnormalities after ablation AF frequently recurs.

MeSH terms

Adult
Aged
Atrial Fibrillation / complications
Atrial Fibrillation / surgery*
Atrioventricular Node / physiopathology
Catheter Ablation / methods*
Female
Humans
Male
Middle Aged
Tachycardia, Paroxysmal / complications
Tachycardia, Paroxysmal / physiopathology
Tachycardia, Paroxysmal / surgery*
Tachycardia, Supraventricular / complications
Tachycardia, Supraventricular / physiopathology
Tachycardia, Supraventricular / surgery*